Koropatnick J - Search Results

1

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.

Petrova PS, Viller NN, Wong M, Pang X, Lin GH, Dodge K, Chai V, Chen H, Lee V, House V, Vigo NT, Jin D, Mutukura T, Charbonneau M, Truong T, Viau S, Johnson LD, Linderoth E, Sievers EL, Maleki Vareki S, Figueredo R, Pampillo M, Koropatnick J, Trudel S, Mbong N, Jin L, Wang JC, Uger RA. Petrova PS, et al. Among authors: koropatnick j. Clin Cancer Res. 2017 Feb 15;23(4):1068-1079. doi: 10.1158/1078-0432.CCR-16-1700. Epub 2016 Nov 17. Clin Cancer Res. 2017. PMID: 27856600

2

ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.

Jason TL, Figueredo R, Ferguson PJ, Vincent MD, Berg RW, Koropatnick J. Jason TL, et al. Among authors: koropatnick j. DNA Cell Biol. 2008 May;27(5):229-40. doi: 10.1089/dna.2007.0674. DNA Cell Biol. 2008. PMID: 18358073

3

Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging.

Goldhawk DE, Lemaire C, McCreary CR, McGirr R, Dhanvantari S, Thompson RT, Figueredo R, Koropatnick J, Foster P, Prato FS. Goldhawk DE, et al. Among authors: koropatnick j. Mol Imaging. 2009 May-Jun;8(3):129-39. Mol Imaging. 2009. PMID: 19723470

4

Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.

Di Cresce C, Figueredo R, Ferguson PJ, Vincent MD, Koropatnick J. Di Cresce C, et al. Among authors: koropatnick j. J Pharmacol Exp Ther. 2011 Sep;338(3):952-63. doi: 10.1124/jpet.111.183178. Epub 2011 Jun 14. J Pharmacol Exp Ther. 2011. PMID: 21673071

5

The Effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model.

Hanly L, Figueredo R, Rieder MJ, Koropatnick J, Koren G. Hanly L, et al. Among authors: koropatnick j. Anticancer Res. 2012 Sep;32(9):3791-8. Anticancer Res. 2012. PMID: 22993321

6

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".

Rytelewski M, Ferguson PJ, Maleki Vareki S, Figueredo R, Vincent M, Koropatnick J. Rytelewski M, et al. Among authors: koropatnick j. Mol Ther Nucleic Acids. 2013 Mar 12;2(3):e78. doi: 10.1038/mtna.2013.7. Mol Ther Nucleic Acids. 2013. PMID: 23481354 Free PMC article.

7

Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI.

Rohani R, Figueredo R, Bureau Y, Koropatnick J, Foster P, Thompson RT, Prato FS, Goldhawk DE. Rohani R, et al. Among authors: koropatnick j. Mol Imaging Biol. 2014 Feb;16(1):63-73. doi: 10.1007/s11307-013-0661-8. Mol Imaging Biol. 2014. PMID: 23836502

8

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin.

Maleki Vareki S, Rytelewski M, Figueredo R, Chen D, Ferguson PJ, Vincent M, Min W, Zheng X, Koropatnick J. Maleki Vareki S, et al. Among authors: koropatnick j. Oncotarget. 2014 May 15;5(9):2778-91. doi: 10.18632/oncotarget.1916. Oncotarget. 2014. PMID: 24784564 Free PMC article.

9

BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.

Rytelewski M, Tong JG, Buensuceso A, Leong HS, Maleki Vareki S, Figueredo R, Di Cresce C, Wu SY, Herbrich SM, Baggerly KA, Romanow L, Shepherd T, Deroo BJ, Sood AK, Chambers AF, Vincent M, Ferguson PJ, Koropatnick J. Rytelewski M, et al. Among authors: koropatnick j. Mol Oncol. 2014 Dec;8(8):1429-40. doi: 10.1016/j.molonc.2014.05.017. Epub 2014 Jun 6. Mol Oncol. 2014. PMID: 24974076 Free PMC article.

10

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.

Di Cresce C, Figueredo R, Rytelewski M, Maleki Vareki S, Way C, Ferguson PJ, Vincent MD, Koropatnick J. Di Cresce C, et al. Among authors: koropatnick j. Oncotarget. 2015 Sep 8;6(26):22397-409. doi: 10.18632/oncotarget.4272. Oncotarget. 2015. PMID: 26087398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters